Mayu Higuchi

1.4k total citations
37 papers, 583 citations indexed

About

Mayu Higuchi is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mayu Higuchi has authored 37 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hepatology, 29 papers in Epidemiology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mayu Higuchi's work include Liver Disease Diagnosis and Treatment (26 papers), Hepatitis B Virus Studies (16 papers) and Hepatitis C virus research (16 papers). Mayu Higuchi is often cited by papers focused on Liver Disease Diagnosis and Treatment (26 papers), Hepatitis B Virus Studies (16 papers) and Hepatitis C virus research (16 papers). Mayu Higuchi collaborates with scholars based in Japan, United States and United Kingdom. Mayu Higuchi's co-authors include Masayuki Kurosaki, Namiki Izumi, Yutaka Yasui, Nobuharu Tamaki, Hiroyuki Nakanishi, Yuka Takahashi, Jun Itakura, Kenta Takaura, Kaoru Tsuchiya and Hitomi Takada and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Mayu Higuchi

37 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mayu Higuchi Japan 17 433 407 66 56 54 37 583
Kenta Takaura Japan 15 424 1.0× 387 1.0× 69 1.0× 48 0.9× 55 1.0× 41 564
Chisa Kondo Japan 15 336 0.8× 289 0.7× 61 0.9× 43 0.8× 40 0.7× 45 487
Fujimasa Tada Japan 12 382 0.9× 263 0.6× 43 0.7× 57 1.0× 24 0.4× 36 564
Han Ah Lee South Korea 11 438 1.0× 360 0.9× 45 0.7× 41 0.7× 27 0.5× 46 563
Yuta Wakui Japan 13 276 0.6× 199 0.5× 60 0.9× 88 1.6× 17 0.3× 23 467
Jorge Daruich Argentina 12 429 1.0× 479 1.2× 29 0.4× 28 0.5× 20 0.4× 40 641
Naoto Kawabe Japan 14 402 0.9× 385 0.9× 26 0.4× 21 0.4× 52 1.0× 46 579
Nicola Alessi Italy 11 487 1.1× 421 1.0× 15 0.2× 41 0.7× 25 0.5× 21 642
Yukihisa Fujinaga Japan 14 202 0.5× 139 0.3× 66 1.0× 105 1.9× 43 0.8× 46 418
Hiromi Kan Japan 16 317 0.7× 273 0.7× 19 0.3× 52 0.9× 20 0.4× 32 460

Countries citing papers authored by Mayu Higuchi

Since Specialization
Citations

This map shows the geographic impact of Mayu Higuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayu Higuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayu Higuchi more than expected).

Fields of papers citing papers by Mayu Higuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayu Higuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayu Higuchi. The network helps show where Mayu Higuchi may publish in the future.

Co-authorship network of co-authors of Mayu Higuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Mayu Higuchi. A scholar is included among the top collaborators of Mayu Higuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayu Higuchi. Mayu Higuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Higuchi, Mayu, Yuki Abiko, Jumpei Washio, & Nobuhiro Takahashi. (2024). Antimicrobial effects of epigallocatechin-3-gallate, a catechin abundant in green tea, on periodontal disease-associated bacteria. Archives of Oral Biology. 167. 106063–106063. 8 indexed citations
2.
3.
Tamaki, Nobuharu, Masayuki Kurosaki, Yuka Takahashi, et al.. (2024). Concordance between metabolic dysfunction‐associated steatotic liver disease and nonalcoholic fatty liver disease. Hepatology Research. 54(6). 600–605. 17 indexed citations
4.
Tamaki, Nobuharu, Hiroaki Matsumoto, Mayu Higuchi, et al.. (2023). A Comparison of Alanine Aminotransferase Normalization between Pemafibrate and Bezafibrate in Patients with Nonalcoholic Fatty Liver Disease. Internal Medicine. 63(9). 1185–1190. 4 indexed citations
5.
Takaura, Kenta, Masayuki Kurosaki, Kento Inada, et al.. (2022). The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy. PLoS ONE. 17(2). e0264075–e0264075. 2 indexed citations
6.
Sekiguchi, Shuhei, Kaoru Tsuchiya, Yutaka Yasui, et al.. (2022). Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy. Cancer Reports. 5(11). e1613–e1613. 9 indexed citations
7.
Kirino, Sakura, Nobuharu Tamaki, Masayuki Kurosaki, et al.. (2021). Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment. Journal of Viral Hepatitis. 28(5). 787–794. 5 indexed citations
8.
Tamaki, Nobuharu, Masayuki Kurosaki, Yuka Takahashi, et al.. (2020). Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup. International Journal of Molecular Sciences. 22(1). 40–40. 9 indexed citations
9.
Tamaki, Nobuharu, Mayu Higuchi, Masayuki Kurosaki, et al.. (2019). Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver disease. Scientific Reports. 9(1). 10109–10109. 27 indexed citations
10.
Takada, Hitomi, Masayuki Kurosaki, Hiroyuki Nakanishi, et al.. (2019). Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures. PLoS ONE. 14(2). e0211122–e0211122. 17 indexed citations
11.
Tamaki, Nobuharu, Masayuki Kurosaki, Sakura Kirino, et al.. (2019). Hepatitis B surface antigen reduction as a result of switching from long‐term entecavir administration to tenofovir. JGH Open. 4(3). 429–432. 10 indexed citations
12.
Takada, Hitomi, Masayuki Kurosaki, Hiroyuki Nakanishi, et al.. (2018). Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma. PLoS ONE. 13(6). e0198812–e0198812. 48 indexed citations
13.
Higuchi, Mayu, Nobuharu Tamaki, Masayuki Kurosaki, et al.. (2018). Prediction of Hepatocellular Carcinoma After Sustained Virological Responses Using Magnetic Resonance Elastography. Clinical Gastroenterology and Hepatology. 17(12). 2616–2618. 16 indexed citations
14.
Komiyama, Yasuyuki, Masayuki Kurosaki, Hiroyuki Nakanishi, et al.. (2017). Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratio. PLoS ONE. 12(3). e0174649–e0174649. 18 indexed citations
15.
Nakanishi, Hiroyuki, Masayuki Kurosaki, Yuka Takahashi, et al.. (2016). Pretreatment Gastric Lavage Reduces Postoperative Bleeding after Endoscopic Submucosal Dissection for Gastric Neoplasms. PLoS ONE. 11(2). e0149235–e0149235. 5 indexed citations
16.
Nakanishi, Hiroyuki, Masayuki Kurosaki, Kaoru Tsuchiya, et al.. (2016). Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment. Liver Cancer. 5(4). 257–268. 16 indexed citations
17.
Yasui, Yutaka, Tokiya Abe, Masayuki Kurosaki, et al.. (2016). Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular Carcinoma. PLoS ONE. 11(4). e0154558–e0154558. 38 indexed citations
18.
Tamaki, Nobuharu, Masayuki Kurosaki, Mayu Higuchi, et al.. (2015). Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens. PLoS ONE. 10(9). e0137351–e0137351. 19 indexed citations
19.
Itakura, Jun, Masayuki Kurosaki, Mayu Higuchi, et al.. (2015). Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based Therapy. PLoS ONE. 10(9). e0138060–e0138060. 16 indexed citations
20.
Nakanishi, Hiroyuki, Masayuki Kurosaki, Takanori Hosokawa, et al.. (2015). Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites. Journal of Gastroenterology. 51(6). 620–627. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenta Takaura Breakdown of academic impact, for papers by Chisa Kondo Breakdown of academic impact, for papers by Fujimasa Tada Breakdown of academic impact, for papers by Han Ah Lee Breakdown of academic impact, for papers by Yuta Wakui Breakdown of academic impact, for papers by Jorge Daruich Breakdown of academic impact, for papers by Naoto Kawabe Breakdown of academic impact, for papers by Nicola Alessi Breakdown of academic impact, for papers by Yukihisa Fujinaga Breakdown of academic impact, for papers by Hiromi Kan
Rankless by CCL
2026